These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14271779)

  • 1. [ON THE DETERMINATION OF THE NEUROVIRULENCE OF LIVE POLIOVIRUS VACCINES. II. PATHOMORPHOLOGY OF APE POLIOMYELITIS CAUSED BY ATTENUATED POLIOVIRUSES AFTER INTRALUMBAR INJECTION WITH SPECIAL REFERENCE TO DIFFERENCES BETWEEN THE VIRUS TYPES].
    UNTERHARNSCHEIDT F; BONIN O
    Arch Psychiatr Nervenkr; 1965 Mar; 206():454-73. PubMed ID: 14271779
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDIES ON THE SALK AND LIVE ATTENUATED POLIOVIRUS VACCINE.
    NISHIZAWA Y; KODAMA T; MAJIMA E; ARAKI M; CHIN S
    Biken J; 1963 Jul; 6():97-110. PubMed ID: 14147708
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the neurovirulence test of poliomyelitis-live vaccine. IV. Pathomorphology of monkey poliomyelitis through neuropathogenic poliovirus type 3 (Saukett strain) after intralumbar injection in comparison to the attenuated poliovirus strains].
    Unterharnscheidt F; Bonin O; Günther O; Heber L; Schmidt K; Schmidt I; von Mettenheim AE
    Arch Psychiatr Nervenkr (1970); 1966; 208(1):13-23. PubMed ID: 4290952
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the neurovirulence test of poliomyelitis-live vaccine. 3. Pathomorphology of monkey poliomyelitis through attenuated polioviruses after intrathalamic infection under particular consideration of differences between virus types].
    Unterharnscheidt F; Bonin O; Schmidt K; Schmidt I
    Arch Psychiatr Nervenkr (1970); 1966; 208(1):1-12. PubMed ID: 4290953
    [No Abstract]   [Full Text] [Related]  

  • 5. THE PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. I. DERIVATION OF NEW TYPE 3 ATTENUATED POLIOVIRUSES AND THEIR LABORATORY CHARACTERISTICS.
    VONKA V; JANDA Z; SIMON J
    Arch Gesamte Virusforsch; 1964 Jun; 14():599-610. PubMed ID: 14247356
    [No Abstract]   [Full Text] [Related]  

  • 6. A phase contrast microprecipitin test with poliovirus antigens. II. Occurrence and development of microprecipitin antibody after natural inapparent infections, after inoculation of Salk vaccine, after feeding of attenuated live poliovirus vaccine, and in disease caused by polioviruses and other enteroviruses.
    EGGERS HJ; SABIN AB
    Arch Gesamte Virusforsch; 1961; 11():152-75. PubMed ID: 13725917
    [No Abstract]   [Full Text] [Related]  

  • 7. ANTIGENIC VARIATIONS AMONG TYPE III POLIOMYELITIS VIRUSES.
    DEIBEL R; MACDONALD D
    N Y State J Med; 1964 Aug; 64():2058-65. PubMed ID: 14180893
    [No Abstract]   [Full Text] [Related]  

  • 8. [ON THE EFFECT OF DEXTRAN SULFATE ON SABIN ORAL POLIOMYELITIS VACCINAL STRAINS].
    VOSS H
    Z Naturforsch B; 1964 Mar; 19():226-9. PubMed ID: 14175997
    [No Abstract]   [Full Text] [Related]  

  • 9. [POLIOMYELITIS IN THE CHILD. REFERENCES TO VIROLOGICAL FINDINGS].
    GONZALEZ M; SCROGGIE S; DIAZ R
    Rev Chil Pediatr; 1964 Jan; 35():24-8. PubMed ID: 14163294
    [No Abstract]   [Full Text] [Related]  

  • 10. Paralysis after oral poliomyelitis vaccine.
    HINTON GG; DUNCAN IB; RATHBUN JC
    Can Med Assoc J; 1962 Oct; 87(17):915-6. PubMed ID: 13954690
    [No Abstract]   [Full Text] [Related]  

  • 11. INTRATYPIC SERODIFFERENTIATION TESTS ON POLIO TYPE 1 VIRUS STRAINS ISOLATED BEFORE AND AFTER VACCINATION WITH ATTENUATED SABIN TYPE 1 POLIO VACCINE.
    HAHNEMANN F; SIBONI K; GODTFREDSEN A
    Acta Pathol Microbiol Scand; 1964; 61():437-45. PubMed ID: 14164891
    [No Abstract]   [Full Text] [Related]  

  • 12. A STUDY OF SABIN TYPE 1 ORAL VACCINE VIRUS DURING FIVE HUMAN PASSAGES.
    PAVILANIS V; LUSSIER G; FOLEY AR; CHARBONNEAU JH; DIFRANCO E; DUBREUIL R
    Rev Can Biol; 1964 Sep; 23():265-76. PubMed ID: 14237159
    [No Abstract]   [Full Text] [Related]  

  • 13. IN VITRO MARKER OF POLIOVIRUSES OBTAINED FROM HUMAN STOOLS AFTER ADMINISTRATION OF ATTENUATED LIVE POLIOVIRUS VACCINE (SABIN).
    KASAHARA S; YOSHIOKA I; YAMAGISHI H; AIZAWA C
    Kitasato Arch Exp Med; 1963 Dec; 36():77-86. PubMed ID: 14318783
    [No Abstract]   [Full Text] [Related]  

  • 14. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 15. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. II. STUDIES ON TYPE 3 STRAINS.
    FURESZ J; ARMSTRONG RE; MOREAU P; NAGLER FP
    Am J Hyg; 1964 Jul; 80():55-61. PubMed ID: 14192770
    [No Abstract]   [Full Text] [Related]  

  • 16. EXPERIENCE IN THE ADMINISTRATION OF LIVE ATTENUATED POLIOVIRUS VACCINE (SABIN) IN INFANTS, WITH REFERENCE TO THE RELATION BETWEEN POLIO AND NON-POLIO VIRUSES.
    KONISHI S; SASATANI M; HAYAKAWA Y; KUROSE T; ASHIHARA Y
    Shonika Kiyo; 1963; 9():283-96. PubMed ID: 14112921
    [No Abstract]   [Full Text] [Related]  

  • 17. [ON THE NEUROVIRULENCE TEST OF LIVE POLIOVIRUS VACCINES. I. BASES, TECHNIC AND EVALUATION OF THE RESEARCH ON NEUROVIRULENCE MEASUREMENT IN MONKEYS].
    BONIN O; UNTERHARNSCHEIDT F
    Arch Psychiatr Nervenkr; 1964 Nov; 206():260-71. PubMed ID: 14344120
    [No Abstract]   [Full Text] [Related]  

  • 18. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
    Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
    J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. I. STUDIES ON TYPE 1 STRAINS.
    FURESZ J; ARMSTRONG RE; YAROSH W; NAGLER FP
    Am J Hyg; 1964 Jul; 80():45-54. PubMed ID: 14192769
    [No Abstract]   [Full Text] [Related]  

  • 20. Proposed method and evaluation of the monkey neurovirulence test for attenuated poliovirus vaccine.
    JUNGHERR EL; CABASSO VJ; MOYER AW; COX HR
    J Infect Dis; 1961; 108():247-61. PubMed ID: 13791071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.